Braidwell »

Transmedics Group shares owned by Braidwell

Quarter-by-quarter ownership of Transmedics Group (TMDX) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Transmedics Group

Tip: Access up to 7 years of quarterly data

All positions including Transmedics Group held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transmedics Group by Braidwell

Quarter filed Position value Share count Share price at filing
2023-12-31 $9.3M 118k 78.93
2023-09-30 $17M 307k 54.75
2023-03-31 $7.5M 99k 75.73
2022-12-31 $19M 303k 61.72

More positions owned by Braidwell

Guardant Health Note 11/1 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
Exact Sciences Corp Note 0.375% 3/0 (Principal)
Novocure Note 11/0 (Principal)
Neurocrine Biosciences (NBIX)
Vaxcyte (PCVX)
Xenon Pharmaceuticals (XENE)
Nuvasive Note 0.375% 3/1 (Principal)
Insulet Corp Note 0.375% 9/0 (Principal)
Tandem Diabetes Care Note 1.500% 5/0 (Principal)
Day One Biopharmaceuticals I (DAWN)
Irhythm Technologies (IRTC)
Argenx Se Sponsored Adr (ARGX)
Bridgebio Pharma Note 2.250% 2/0 (Principal)

View all positions for Braidwell

Top funds holding Transmedics Group

Vanguard Group
Fred Alger Management
Lord, Abbett & Co
Arrowpoint Asset Management
Eventide Asset Management
Credit Suisse
Sandhill Capital Partners
First Light Asset Management
Allspring Global Investments Holdings
Bank of New York Mellon
Bellevue Group
Emerald Advisers
Mackenzie Financial
Emerald Mutual Fund Advisers, Trust
Goldman Sachs Group

View all funds holding Transmedics Group